BrightOwl Loader Loading


Current Experience

  • Director, Safety Lead Neuroscience New Medicines Belgium
    Since April 2015

    Member of the project governance teams. Strategic leadership in safety and risk managemnet for Phase 1-2 pipeline products in CNS TA (Epilepsy, Parkinson's Disease). Coordination of the crossfunctional Mission Team deliverables, benefit-risk team leadership, matrix team leader at Patient Safety. Key deliverables: safety  risk management strategy, benefit-risk assessment, safety measures and outcomes in clinical development plan, study protocols, scientific advice with HA, safety differentiation for target product profile.

Past Experience

  • Director, Safety Physician/Safety Lead Established Products
    April 2013 --- March 2015
    Coordination of cross-functional drug safety deliverables, signal and benefit-risk assessments.

  • Head of Medical and Scientific Expertise EU at Drug Safety
    May 2012 --- March 2013

  • Safety Director & Head of Internal Medicine EU, Global Clinical Safety and Pharmacovigilance
    March 2011 --- April 2012

  • Associate Director Global Drug Safety and Pharmacovigilance
    January 2008 --- February 2011

  • Clinical Project Leader and Project Manager
    January 2007 --- December 2007
    Coordination of a pharmaceutical product lyfe cycle team in transition of a product from pre-clinical to clinical phases. Providing Target Product Profile, Clinical Development Plan

  • Clinical Research Physician
    May 2002 --- December 2006
    Clinical Development, CNS, phases IIb - IV, Medical Affairs responsibility

  • CRA/ Clinical Team Leader Moscow, Russia
    August 2000 --- May 2002

  • Post-Graduate Specialization and Research
    August 1997 --- December 2001


Self Assessment :
Strategic thinkingCritical thinkingInnovative thinkingOrganizationCoordinationAssertivenessCollaborationAdaptabilityAuthenticity


Self Assessment :
Clinical researchBusiness DevelopmentClinical DevelopmentDrug development processDrug DevelopmentEarly development stageKnowledge of the drug development processDeveloping Clinical Trial ProtocolsPharmaceutical DevelopmentPhases of clinical development (phase I to IV)Product developmentMarket researchPre-clinical research R&DCompliance with regulationsClinical study reportsInterpret clinical trial resultsTranslational MedicineNew Business DevelopmentDrug Safety and PharmacovigilancePreclinical Safety
LinkedIn Assessment :
PharmacovigilanceClinical DevelopmentClinical researchGCPDrug SafetyMedical affairsCROSOPEpilepsyNeurologyPsychiatrySafety Risk ManagementBusiness Strategy


  • Master of Business Administration (MBA) in Business Administration and Management, General from University of Phoenix in 2014
  • Doctor of Medicine (MD) in from First Moscow State Medical University named after I.M. Sechenov in 1997

Area / Region



Driving License
  • Yes